Egypt’s Hepatitis C Program: A Model for ...

By Crystal Lubbe

December 12, 2024

The article from the Africa CDC website, titled "Egypt's Hepatitis Programme Becomes a Model for African Countries," highlights Egypt's su...
Maturity Level 3 in Medicines Regulation in Senegal and Rwanda
Infection Control and Disease Surveillance in Africa
CMS Price Negotiations: Bridging the Gap in US Drug Pricing
Access to Anti-Obesity Medication for Medicare and Medicaid
Canada’s Drug Agency Launches Consultation on New Methods Guide for Hea...
Sanofi’s 340B Rebate Model: A Joint Effort to Reform Drug Pricing Pract...
Addressing Physical Inactivity in MENA and Beyond
Smartening Africa’s Drug Supply Chain with IBM AI
Enhancing Primary Health Care Services: Strategies and Insights
Transforming Healthcare: Key Trends in South African Healthtech
Boosting Biopharma SMEs in Europe
Lawsuits Challenge 340B Drug Pricing Program: Eli Lilly and J&J vs. HRSA